HGHRX | JFNIX | HGHRX / JFNIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 18 years | 15 years | - |
Gain YTD | -3.343 | 1.564 | -214% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 952M | 5.25B | 18% |
Annual Yield % from dividends | 0.00 | 0.15 | - |
Returns for 1 year | -0.93 | 4.55 | -20% |
Returns for 3 years | -10.96 | -4.26 | 257% |
Returns for 5 years | -6.20 | 19.37 | -32% |
Returns for 10 years | -3.78 | 36.65 | -10% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
REK | 17.18 | 0.09 | +0.54% |
ProShares Short Real Estate | |||
MARW | 31.16 | -0.03 | -0.08% |
AllianzIM U.S. Large Cp Buffer20 Mar ETF | |||
BSMR | 23.70 | -0.06 | -0.25% |
Invesco BulletShares 2027 Muncpl Bd ETF | |||
ISCG | 51.84 | -0.59 | -1.12% |
iShares Morningstar Small-Cap Growth ETF | |||
VIOO | 112.57 | -1.57 | -1.38% |
Vanguard S&P Small-Cap 600 ETF |